Home »
Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011

Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Email to a Colleague - Print - Fax Order

Additional Information

Price	$1,000.00
Publisher	GlobalData
Date of Report	Jun 21, 2011

Add to Wishlist | Add to Compare

Qty:

-OR-

Quick Overview

Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011" provides data on theLip and Oral Cavity Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials onLip and Oral Cavity Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treatingLip and Oral Cavity Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Lip and Oral Cavity Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Lip and Oral Cavity Cancer 20
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Lip and Oral Cavity Cancer Therapeutics Clinical Trials 25
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Viventia Biotechnologies Inc. 28
Clinical Trial Overview of Viventia Biotechnologies Inc. 28
Pfizer Inc. 29
Clinical Trial Overview of Pfizer Inc. 29
Azienda U.S.L. 4 di Prato 30
Clinical Trial Overview of Azienda U.S.L. 4 di Prato 30
Auspharm Pty Ltd 31
Clinical Trial Overview of Auspharm Pty Ltd 31
Shenzhen SiBiono GeneTech 32
Clinical Trial Overview of Shenzhen SiBiono GeneTech 32
Endo Pharmaceuticals Inc. 33
Clinical Trial Overview of Endo Pharmaceuticals Inc. 33
Clinical Trial Overview of Top Universities / Institutes / Hospitals 34
The University of Texas M. D. Anderson Cancer Center 34
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 34
Tata Memorial Hospital 35
Clinical Trial Overview of Tata Memorial Hospital 35
Fred Hutchinson Cancer Research Center-Technology Transfer 36
Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer 36
Institut Gustave Roussy 37
Clinical Trial Overview of Institut Gustave Roussy 37
Stanford University 38
Clinical Trial Overview of Stanford University 38
UCLA's Jonsson Comprehensive Cancer Center 39
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 39
Memorial Sloan Kettering Cancer Center 40
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 40
Abramson Cancer Center 41
Clinical Trial Overview of Abramson Cancer Center 41
Groupe Oncologie Radiotherapie Tete et Cou 42
Clinical Trial Overview of Groupe Oncologie Radiotherapie Tete et Cou 42
Ministry of Science & Technology 43
Clinical Trial Overview of Ministry of Science & Technology 43
Sapporo Medical University 44
Clinical Trial Overview of Sapporo Medical University 44
Johannes Gutenberg University Mainz 45
Clinical Trial Overview of Johannes Gutenberg University Mainz 45
Mount Sinai School of Medicine 46
Clinical Trial Overview of Mount Sinai School of Medicine 46
Virginia Commonwealth University 47
Clinical Trial Overview of Virginia Commonwealth University 47
Cantonal Hospital of St. Gallen 48
Clinical Trial Overview of Cantonal Hospital of St. Gallen 48
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute 49
Clinical Trial Overview of Arthur G. James Cancer Hospital & Richard J. Solove Research Institute 49
The University of British Columbia 50
Clinical Trial Overview of The University of British Columbia 50
VCU Massey Cancer Center 51
Clinical Trial Overview of VCU Massey Cancer Center 51
University of Michigan Comprehensive Cancer Center 52
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 52
Roswell Park Cancer Institute 53
Clinical Trial Overview of Roswell Park Cancer Institute 53
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 56